en
Scientific article
English

Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through Inhibition of Neutrophil Activation

Published inJournal of investigative dermatology, vol. 133, no. 10, p. 2390-2399
Publication date2013
Abstract

Corticosteroids are regularly used to treat autoimmune diseases, such as bullous pemphigoid (BP). In BP, autoantibodies bind to type XVII collagen (COL17), located at the dermal-epidermal junction. A crucial role of neutrophils in experimental BP has been established. Specifically, reactive oxygen species and proteolytic granule enzymes mediate tissue injury. Therefore, we investigated the effects of methylprednisolone (MP) on neutrophils, which are likely to be affected by topical treatment. First, MP inhibited dermal-epidermal separation ex vivo in cryosections of the human skin induced by co-incubation of BP autoantibodies with neutrophils from healthy volunteers. Next, MP inhibited neutrophil activation in vitro induced by immune complexes (ICs) of COL17 and autoantibodies. This neutrophil activation was associated with phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), p38 mitogen-activated protein kinase (MAPK), and Akt. In turn, inhibition of ERK1/2, p38 MAPK, or Akt phosphorylation inhibited neutrophil activation by IC in vitro and dermal-epidermal separation ex vivo. In addition, we observed an increase of p38 MAPK phosphorylation in dermal infiltrates of BP patients. Treatment of mice with either MP or inhibitors of p38-MAPK or ERK1/2 phosphorylation impaired induction of autoantibody- or irritant-induced neutrophil-dependent inflammation. We here identify the inhibition of Akt, ERK1/2, and p38 MAPK phosphorylation as molecular mechanisms to promote MP's therapeutic effects.Journal of Investigative Dermatology advance online publication, 4 April 2013; doi:10.1038/jid.2013.91.

Affiliation Not a UNIGE publication
Citation (ISO format)
HELLBERG, Lars et al. Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through Inhibition of Neutrophil Activation. In: Journal of investigative dermatology, 2013, vol. 133, n° 10, p. 2390–2399. doi: 10.1038/jid.2013.91
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0022-202X
530views
1downloads

Technical informations

Creation09/20/2013 4:48:26 PM
First validation09/20/2013 4:48:26 PM
Update time03/14/2023 8:25:18 PM
Status update03/14/2023 8:25:18 PM
Last indexation01/16/2024 2:10:13 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack